News

Commission continues approving funding for telehealth during coronavirus pandemic.

Amid COVID-19 Outbreak, U.S. Dental Triage is Partnering with Dentists to Donate Face Masks and PPE to First Responders.

Dr. Mark Ruchman, chief medical officer, Versant Health, shares eye safety tips and ways to best stay protected from COVID-19 as guidelines are loosened throughout the country.

Antigen tests, a new category, have a major advantage and disadvantage over COVID-19 tests already approved.

The onset of COVID-19 has doubled the percentage of American adults who have tried telemedicine as an alternative to a doctor’s office visit.

Numerous PPEs and testing kits also feature unproven coronavirus claims.

Dr. Robert Posner, who specializes in helping people lose weight, offers preparedness advice.

Men have higher concentrations of ACE2 in their blood.  

His departure would add to the narrative of disappointment in the healthcare ventured backed by Amazon, Berkshire Hathaway, and JPMorgan Chase.

The Advanced Medical Technology Association (AdvaMed) recently announced availability of a new “Code of Ethics Compliance Guidance Related to the COVID-19 Response.”

Dr. Vivek Garg, CareMore and Aspire chief medical officer, discusses palliative home-based care and its effects of COVID-19.

All across the country, and in fact globally, musculoskeletal (MSK) care has become difficult if not impossible for most patients to access because of the COVID-19 pandemic.

As social distancing has become the new norm due to COVID-19, the new normal for healthcare has also seen a rise of telehealth services. However, there are security risks involved for patients’ personal data and companies’ private information.

As employers plan to return to the workplace, Mercer survey reveals key considerations from employers’ experience with essential workers and COVID-19.

The FDA recently approved AstraZeneca’s Farxiga (dapagliflozin) for the treatment of heart failure with reduced ejection fraction (HFrEF) in adults with and without type 2 diabetes, marking the first time a drug in a class developed for diabetes was approved for heart failure even if diabetes is not present.

Merlo says COVID-19 related business activity added 10 cents to the adjusted earnings per share.

Independent research finds COVID-19 testing costs can vary by hundreds of dollars per test, with billions of dollars at risk nationwide.

A strong interferon response may lead to harmful cytokine storms.

About 80% of the losses are from cancelled surgeries and over services.

Formulation could cause fewer administration-related reactions than IV Darzalex.

NEMEXIS, an international anti-fraud consulting firm based in Berlin, reported fraud and corruption affecting healthcare and healthcare systems spurred whistleblower activity in half of the 58 countries in the survey.

Popular heartburn medication now in shortage due to COVID-19 test.

ICER's pricing model ranges from $10 to $52,880

The Whole Person Care pilot program has proven to be essential for communities in California and could potentially do the same in communities around the world.